-
Je něco špatně v tomto záznamu ?
Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
K. Vrzalikova, T. Sunmonu, G. Reynolds, P. Murray,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2012
Free Medical Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2012-03-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
29954084
DOI
10.3390/pathogens7030059
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Pathogenic viruses have evolved to manipulate the host cell utilising a variety of strategies including expression of viral proteins to hijack or mimic the activity of cellular functions. DNA tumour viruses often establish latent infection in which no new virions are produced, characterized by the expression of a restricted repertoire of so-called latent viral genes. These latent genes serve to remodel cellular functions to ensure survival of the virus within host cells, often for the lifetime of the infected individual. However, under certain circumstances, virus infection may contribute to transformation of the host cell; this event is not a usual outcome of infection. Here, we review how the Epstein⁻Barr virus (EBV), the prototypic oncogenic human virus, modulates host cell functions, with a focus on the role of the EBV latent genes in classical Hodgkin lymphoma.
Institute for Cancer and Genomic Medicine University of Birmingham Birmingham B15 2TT UK
Institute of Immunology and Immunotherapy University of Birmingham Birmingham B15 2TT UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18023926
- 003
- CZ-PrNML
- 005
- 20180719082933.0
- 007
- ta
- 008
- 180709s2018 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/pathogens7030059 $2 doi
- 035 __
- $a (PubMed)29954084
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Vrzalikova, Katerina $u Institute for Cancer and Genomic Medicine, University of Birmingham, Birmingham B15 2TT, UK. k.vrzalikova@bham.ac.uk.
- 245 10
- $a Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma / $c K. Vrzalikova, T. Sunmonu, G. Reynolds, P. Murray,
- 520 9_
- $a Pathogenic viruses have evolved to manipulate the host cell utilising a variety of strategies including expression of viral proteins to hijack or mimic the activity of cellular functions. DNA tumour viruses often establish latent infection in which no new virions are produced, characterized by the expression of a restricted repertoire of so-called latent viral genes. These latent genes serve to remodel cellular functions to ensure survival of the virus within host cells, often for the lifetime of the infected individual. However, under certain circumstances, virus infection may contribute to transformation of the host cell; this event is not a usual outcome of infection. Here, we review how the Epstein⁻Barr virus (EBV), the prototypic oncogenic human virus, modulates host cell functions, with a focus on the role of the EBV latent genes in classical Hodgkin lymphoma.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Sunmonu, Taofik $u Institute for Cancer and Genomic Medicine, University of Birmingham, Birmingham B15 2TT, UK. taosun77@gmail.com.
- 700 1_
- $a Reynolds, Gary $u Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK. g.m.reynolds@bham.ac.uk.
- 700 1_
- $a Murray, Paul $u Institute for Cancer and Genomic Medicine, University of Birmingham, Birmingham B15 2TT, UK. p.g.murray@bham.ac.uk. Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 775 15 Olomouc, Czech Republic. p.g.murray@bham.ac.uk.
- 773 0_
- $w MED00195469 $t Pathogens (Basel, Switzerland) $x 2076-0817 $g Roč. 7, č. 3 (2018)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29954084 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180719083233 $b ABA008
- 999 __
- $a ind $b bmc $g 1315913 $s 1020844
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 7 $c 3 $e 20180627 $i 2076-0817 $m Pathogens $n Pathogens $x MED00195469
- LZP __
- $a Pubmed-20180709